First Patient Enrollment in AGILITY Study Begins Investigations of Safety and Effectiveness of BD Vascular Covered Stent for Treatment of PAD FRANKLIN LAKES, N.J., March 4, 2024 /PRNewswire/ -- BD ...
6hon MSN
Patients with peripheral arterial disease and Afib found to face higher risk for cardiac events
New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) ...
New studies underscore the importance of inclusive approaches in peripheral artery disease treatment
New clinical results highlight the need for inclusive approaches and comprehensive examinations of treatment options for peripheral artery disease (PAD), including endovascular therapy and ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY Investigational Device ...
The FDA approved the Esprit BTK everolimus-eluting scaffold system for chronic limb-threatening ischemia (CLTI) below the knee, Abbott announced on Monday. This system represents the first ...
Peripheral artery disease (PAD) involves a debilitating narrowing of arteries in the legs, and the National Institutes of Health estimates that 1 in every 20 Americans over 50 is affected. Research ...
PAD typically onsets with no noticeable symptoms. Over time, it can progress and begin causing limb pain and cramping, even when at rest. Early treatment can help to slow the progression and reduce ...
Every time Rebecca publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...
Stellarex’s unique coating enables a low therapeutic drug dose and has demonstrated a significant treatment effect and high safety profile Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback